Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiona Carr

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Diabetes Care|October 25, 2018
A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody-Positive Type 2 Diabetes Who Rapidly Progress to Insulin TherapyAnita L Grubb, Timothy J McDonald, Femke Rutters, et al.
Clinical Pharmacology and Therapeutics|June 5, 2020
Exome Sequencing Reveals Common and Rare Variants in F5 Associated With ACE Inhibitor and Angiotensin Receptor Blocker-Induced AngioedemaCyrielle Maroteau, Moneeza Kalhan Siddiqui, Abirami Veluchamy, et al.
European Heart Journal|October 12, 2017
A common missense variant of LILRB5 is associated with statin intolerance and myalgiaMoneeza K Siddiqui, Cyrielle Maroteau, Abirami Veluchamy, et al.
Nature Genetics|December 28, 2010
Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes, , Kaixin Zhou, et al.
Nature Communications|October 29, 2014
Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statinsIris Postmus, Stella Trompet, Harshal A Deshmukh, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Diabetes Care|October 25, 2018
A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody-Positive Type 2 Diabetes Who Rapidly Progress to Insulin TherapyAnita L Grubb, Timothy J McDonald, Femke Rutters, et al.
Clinical Pharmacology and Therapeutics|June 5, 2020
Exome Sequencing Reveals Common and Rare Variants in F5 Associated With ACE Inhibitor and Angiotensin Receptor Blocker-Induced AngioedemaCyrielle Maroteau, Moneeza Kalhan Siddiqui, Abirami Veluchamy, et al.
European Heart Journal|October 12, 2017
A common missense variant of LILRB5 is associated with statin intolerance and myalgiaMoneeza K Siddiqui, Cyrielle Maroteau, Abirami Veluchamy, et al.
Nature Genetics|December 28, 2010
Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes, , Kaixin Zhou, et al.
Nature Communications|October 29, 2014
Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statinsIris Postmus, Stella Trompet, Harshal A Deshmukh, et al.
Pageof 4